Kezitil achieves first time success in community acquired bacterial infections
Kezitil is active against a wide range of resistant bacteria.
Kezitil achieves first time success in community acquired bacterial infections
Pharmanews Limited is a health care publishing, training and consultancy firm, positioned to ensure consistent improvements in the quality of pharmaceutical and health care services through publishing and training.
Pages
© 2025 Pharmanews Limited. All rights reserved.